Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Characterization of "Early-Start" Participants that Continued Receiving Donanemab in the TRAILBLAZER-ALZ 2 Long-Term Extension Period

Author:Schreiber, Curt   Schilling, Traci   Doty, Erin   Yang, Fan   Sato, Shoichiro   Zimmer, Jennifer   

Session Name:LS2: Late-breaking Science 2  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:Aging, Dementia, and Behavioral Neurology  

Author Institution:Missouri Memory Center, Bolivar, MO  Eli Lilly and Company, Indianapolis, IN